… of this review was to determine whether beta2‐agonists are effective symptomatic treatment
for patients without underlying pulmonary disease who present with acute bronchitis. …

Background The diagnosis of acute bronchitis is made on clinical grounds and a variety of
clinical definitions have been used. There are no clearly effective treatments for the cough of …

… was to determine whether beta2‐agonists are effective symptomatic treatment for patients
without underlying pulmonary disease who present with acute bronchitis. Specifically, we: …

… Are beta2 agonists effective for improving symptoms of acute cough or a clinical diagnosis
of acute bronchitis … There is insufficient evidence to determine whether beta2 agonists can …

… The systematic review by Smucny and colleagues provides compelling evidence against the
routine use of beta^sub 2^-agonists for the treatment of cough associated with acute bronchitis …

… This overview is limited to episodes of acute bronchitis in people (smokers and non-smokers…
the following options, analgesics and oral beta2 agonists, from this overview. Data and …

… Short acting beta2‐agonists and ipratropium are widely used in the management of acute …
This review was originally designed to assess the benefit of short‐acting beta2‐agonists alone …

… Inhaled Beta2-Agonists (Bronchodilators) see … BRONCHITIS (AECB) Comment: Antibiotics
are seldom needed for treatment of acute bronchitis because the etiology is usually viral…

… Acute bronchitis is transient inflammation of the trachea and major bronchi. Clinically, it is …
This review is limited to episodes of acute bronchitis in people (smokers and nonsmokers) …

… of beta2-agonists compared with placebo for the treatment of acute cough or acute bronchitis
… For patients with acute cough and wheezing, subgroup analysis of 15 patients from 1 RCT …